nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.114	0.126	CbGbCtD
Ximelagatran—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.107	0.118	CbGbCtD
Ximelagatran—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.107	0.118	CbGbCtD
Ximelagatran—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0971	0.107	CbGbCtD
Ximelagatran—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0971	0.107	CbGbCtD
Ximelagatran—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0838	0.0925	CbGbCtD
Ximelagatran—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0814	0.0898	CbGbCtD
Ximelagatran—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0736	0.0812	CbGbCtD
Ximelagatran—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0736	0.0812	CbGbCtD
Ximelagatran—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0705	0.0779	CbGbCtD
Ximelagatran—F2—endothelium—acquired immunodeficiency syndrome	0.0101	0.194	CbGeAlD
Ximelagatran—F2—blood plasma—acquired immunodeficiency syndrome	0.00897	0.172	CbGeAlD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.00459	0.11	CbGpPWpGaD
Ximelagatran—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00357	0.0687	CbGeAlD
Ximelagatran—F2—lymphoid tissue—acquired immunodeficiency syndrome	0.00349	0.0671	CbGeAlD
Ximelagatran—F2—digestive system—acquired immunodeficiency syndrome	0.00345	0.0663	CbGeAlD
Ximelagatran—F2—blood—acquired immunodeficiency syndrome	0.00329	0.0631	CbGeAlD
Ximelagatran—F2—bone marrow—acquired immunodeficiency syndrome	0.00318	0.0611	CbGeAlD
Ximelagatran—F2—spinal cord—acquired immunodeficiency syndrome	0.00317	0.0608	CbGeAlD
Ximelagatran—F2—lung—acquired immunodeficiency syndrome	0.00288	0.0553	CbGeAlD
Ximelagatran—F2—nervous system—acquired immunodeficiency syndrome	0.00267	0.0512	CbGeAlD
Ximelagatran—F2—central nervous system—acquired immunodeficiency syndrome	0.00257	0.0493	CbGeAlD
Ximelagatran—F2—Syndecan-4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.00211	0.0506	CbGpPWpGaD
Ximelagatran—F2—Syndecan-4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.00211	0.0506	CbGpPWpGaD
Ximelagatran—F2—brain—acquired immunodeficiency syndrome	0.00204	0.0392	CbGeAlD
Ximelagatran—F2—Syndecan-4-mediated signaling events—CCL5—acquired immunodeficiency syndrome	0.00161	0.0385	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.0016	0.0382	CbGpPWpGaD
Ximelagatran—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.00137	0.0264	CbGeAlD
Ximelagatran—CYP2C9—blood—acquired immunodeficiency syndrome	0.00131	0.0252	CbGeAlD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—IFNG—acquired immunodeficiency syndrome	0.00119	0.0284	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.00111	0.0265	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00107	0.0256	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.00102	0.0244	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000968	0.0231	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000875	0.0209	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.000873	0.0209	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000816	0.0195	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	0.0008	0.0191	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000757	0.0181	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.000711	0.017	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000649	0.0155	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000649	0.0155	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000598	0.0143	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000587	0.014	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.000579	0.0138	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000541	0.0129	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000528	0.0126	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000508	0.0122	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000508	0.0122	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000494	0.0118	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000469	0.0112	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.00046	0.011	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000447	0.0107	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.000427	0.0102	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.00042	0.01	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000419	0.01	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000419	0.01	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000401	0.00959	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000387	0.00925	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000363	0.00867	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000348	0.00833	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000342	0.00817	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000341	0.00816	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000341	0.00816	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000339	0.00811	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000338	0.00807	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000305	0.0073	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000276	0.00661	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000276	0.00659	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000271	0.00649	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00026	0.00621	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00026	0.00621	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000259	0.0062	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000254	0.00607	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000247	0.00592	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000234	0.00559	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000229	0.00549	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000222	0.00532	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.00022	0.00526	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000219	0.00524	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000198	0.00472	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000178	0.00427	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000178	0.00426	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000174	0.00416	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000164	0.00391	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000157	0.00375	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000156	0.00373	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00015	0.00358	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00015	0.00358	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000147	0.00351	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000147	0.00351	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000142	0.00339	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000136	0.00324	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000133	0.00319	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000133	0.00319	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000113	0.00271	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000112	0.00267	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00011	0.00263	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000107	0.00256	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000101	0.00242	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000101	0.00241	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.99e-05	0.00239	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.26e-05	0.00221	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2—acquired immunodeficiency syndrome	9.2e-05	0.0022	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.14e-05	0.00218	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	8.56e-05	0.00205	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.37e-05	0.002	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.87e-05	0.00188	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.87e-05	0.00188	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	7.28e-05	0.00174	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.99e-05	0.00143	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.9e-05	0.00141	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.81e-05	0.00139	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.4e-05	0.00129	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.28e-05	0.00126	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.35e-05	0.000802	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.12e-05	0.000746	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.1e-05	0.000742	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.83e-05	0.000438	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	1.49e-05	0.000357	CbGpPWpGaD
